Guidelines : Osteoporosis
Detail
Committee Recommendations
The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed an High Cost drug Osteoporosis pathway as a temporary measure until the entire Algorithm 1 is reviewed.
Abaloparatide has been added to the algorithm following the publication of NICE TA991.
Please note that algorithm 1 in the Osteoporosis Guidelines has not been updated
The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed an updated Osteoporosis Treatment Pathway - Algorithm 1.
Romosozumab has been added to the algorithm following the publication of NICE TA791 in May 2022.
Please note that algorithm 1 in the Osteoporosis Guidelines has not been updated
The Osteoporosis guidelines have been reviewed and updated.
The guidelines are supported by two algorithms which have been extracted from the guideline and provided as separate documents (below) for ease of use:
Algorithm 1 - Treatment Pathway for adults
Algorithm 2 - Review of Long-term Bisphosphonate Therapy
Calcium & vitamin D:
AdcalD3/ AccreteD3 twice daily formulations are the preferred calcium and vitamin D supplements.
Accrete D3 One a Day, Calci-D chewable tablets or theiCal-D3 chewable tablets are once daily options for patients with compliance issues.
Documents
Supplementary documents (CCG specific documents)
No records returned.
Drugs
Below are listed drugs that are used to treat Osteoporosis.
- Abaloparatide Red
- Alendronic acid and colecalciferol Black
- Alendronic acid effervescent tablets Green (see narrative)
- Alendronic acid oral solution Green
- Alendronic acid Tablets Green
- Calcifediol
- Calcium & vitamin D Green
- Denosumab Green (see narrative)
- Ibandronic Acid Green
- Raloxifene Green (see narrative)
- Risedronate sodium Green
- Romosozumab Red
- Strontium ranelate Red
- Teriparatide Red
- Zoledronic acid Red